Viewing Study NCT00301951


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-01-04 @ 12:15 PM
Study NCT ID: NCT00301951
Status: COMPLETED
Last Update Posted: 2017-10-12
First Post: 2006-03-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
Sponsor: University of California, San Francisco
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
None Multiple Myeloma and Plasma Cell Neoplasm View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult acute myeloid leukemia with 11q23 (MLL) abnormalities View
None adult acute myeloid leukemia with inv(16)(p13;q22) View
None adult acute myeloid leukemia with t(15;17)(q22;q12) View
None adult acute myeloid leukemia with t(16;16)(p13;q22) View
None adult acute myeloid leukemia with t(8;21)(q22;q22) View
None accelerated phase chronic myelogenous leukemia View
None adult acute lymphoblastic leukemia in remission View
None adult acute myeloid leukemia in remission View
None angioimmunoblastic T-cell lymphoma View
None blastic phase chronic myelogenous leukemia View
None chronic myelomonocytic leukemia View
None chronic phase chronic myelogenous leukemia View
None de novo myelodysplastic syndromes View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None anaplastic large cell lymphoma View
None nodal marginal zone B-cell lymphoma View
None previously treated myelodysplastic syndromes View
None recurrent adult acute lymphoblastic leukemia View
None recurrent adult acute myeloid leukemia View
None recurrent adult T-cell leukemia/lymphoma View
None recurrent adult Hodgkin lymphoma View
None recurrent adult diffuse large cell lymphoma View
None recurrent cutaneous T-cell non-Hodgkin lymphoma View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent mantle cell lymphoma View
None recurrent marginal zone lymphoma View
None recurrent mycosis fungoides/Sezary syndrome View
None recurrent small lymphocytic lymphoma View
None refractory chronic lymphocytic leukemia View
None stage III adult T-cell leukemia/lymphoma View
None refractory multiple myeloma View
None relapsing chronic myelogenous leukemia View
None secondary acute myeloid leukemia View
None secondary myelodysplastic syndromes View
None splenic marginal zone lymphoma View
None stage I multiple myeloma View
None stage II multiple myeloma View
None stage IV adult T-cell leukemia/lymphoma View
None stage III adult Hodgkin lymphoma View
None stage III adult diffuse large cell lymphoma View
None stage III chronic lymphocytic leukemia View
None stage III grade 1 follicular lymphoma View
None stage III grade 2 follicular lymphoma View
None stage III grade 3 follicular lymphoma View
None stage III mantle cell lymphoma View
None stage III marginal zone lymphoma View
None stage III multiple myeloma View
None stage III small lymphocytic lymphoma View
None stage IV adult Hodgkin lymphoma View
None stage IV adult diffuse large cell lymphoma View
None stage IV chronic lymphocytic leukemia View
None stage IV grade 1 follicular lymphoma View
None stage IV grade 2 follicular lymphoma View
None stage IV grade 3 follicular lymphoma View
None stage IV mantle cell lymphoma View
None stage IV marginal zone lymphoma View
None stage IV small lymphocytic lymphoma View